Research at Memorial Sloan-Kettering will benefit from renewed support for The Starr Cancer Consortium and the Tri-Institutional Stem Cell Initiative totaling $105 million.

Dr. Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan-Kettering, a high-volume center.

Memorial Sloan-Kettering researchers have found that people in the late stages of cancer might benefit from meaning-centered psychotherapy, a treatment aimed at helping people sustain a sense of meaning and purpose.

Researchers have demonstrated a technique that enables specific and accurate labeling of brain tumor tissue in mice. If proven effective in patients, the method could make complete surgical removal of brain tumors more feasible.

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

James Eastham, Chief of Memorial Sloan-Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.

Memorial Sloan-Kettering Cancer Center’s redesigned website has been nominated for Best Health Website for the 16th Annual Webby Awards. We were selected among the best from nearly 10,000 entries.